Učitavanje...
MiR-106a-5p promotes 5-FU resistance and the metastasis of colorectal cancer by targeting TGFβR2
Background: Colorectal cancer (CRC) is the third leading cause of cancer-related deaths. 5-Fluorouracil (5-FU)-based chemotherapy has always been the first-line treatment. However, development of 5-FU resistance seriously affects its curative effect. The aim of this study was to elucidate the molecu...
Spremljeno u:
| Izdano u: | Int J Clin Exp Pathol |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
e-Century Publishing Corporation
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6963073/ https://ncbi.nlm.nih.gov/pubmed/31949649 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|